These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Hepburn AL; Mason JC; Davies KA Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618 [TBL] [Abstract][Full Text] [Related]
6. Expression of IL-2R, IL-4R, IL-6R on peripheral blood lymphocytes in systemic lupus erythematosus and correlation with disease activity: a prospective study. Chan EY; Lau CS; Zola H J Clin Pathol; 1996 Aug; 49(8):660-3. PubMed ID: 8881918 [TBL] [Abstract][Full Text] [Related]
7. Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Cairns AP; Crockard AD; McConnell JR; Courtney PA; Bell AL Ann Rheum Dis; 2001 Oct; 60(10):950-5. PubMed ID: 11557652 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987 [TBL] [Abstract][Full Text] [Related]
9. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138 [TBL] [Abstract][Full Text] [Related]
10. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation. Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [TBL] [Abstract][Full Text] [Related]
12. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus. Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068 [TBL] [Abstract][Full Text] [Related]
13. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307 [TBL] [Abstract][Full Text] [Related]
14. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus. McKenna RM; Wilkins JA; Warrington RJ J Rheumatol; 1988 Nov; 15(11):1639-42. PubMed ID: 3148712 [TBL] [Abstract][Full Text] [Related]
15. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033 [TBL] [Abstract][Full Text] [Related]
16. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787 [TBL] [Abstract][Full Text] [Related]
17. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus. Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047 [TBL] [Abstract][Full Text] [Related]
18. Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus. Itoh M; Goto Y; Ohta Y; Goto Y; Ohashi H Clin Rheumatol; 1998; 17(1):26-30. PubMed ID: 9586675 [TBL] [Abstract][Full Text] [Related]
19. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Portales-Cervantes L; Niño-Moreno P; Doníz-Padilla L; Baranda-Candido L; García-Hernández M; Salgado-Bustamante M; González-Amaro R; Portales-Pérez D Hum Immunol; 2010 Aug; 71(8):818-25. PubMed ID: 20493226 [TBL] [Abstract][Full Text] [Related]
20. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report. Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]